BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8361260)

  • 1. Inspection of clinical investigations by the German health authorities.
    Schmidt M
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):229-31. PubMed ID: 8361260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The inspection by the Danish Medical Products Agency of drug clinical trials].
    Jacobsen E; Stilbo I
    Ugeskr Laeger; 2003 Apr; 165(16):1656-8. PubMed ID: 12756822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of good clinical practice in the EEC and in Germany.
    Anhalt E
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):217-22. PubMed ID: 8361258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differences between clinical trials according to the German law on pharmaceuticals (Arzneimittelgesetz) and trials according to the German law on medical products (Medizinproduktegesetz)].
    Krummenauer F
    Ophthalmologe; 2003 Feb; 100(2):150-4. PubMed ID: 12589461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [GCP inspections of clinical trials].
    Schwarz G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):181-8. PubMed ID: 15726459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?].
    Schwarz S; Frölich L; Striebel JP; Hennerici MG
    Dtsch Med Wochenschr; 2007 Jan; 132(3):108-12. PubMed ID: 17219346
    [No Abstract]   [Full Text] [Related]  

  • 7. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recording and reporting adverse reactions in clinical trials. New legal provisions according to the 12th Law Amending the German Drug Law (AMG) and the Ordinance on GCP (GCP-V)].
    Eckhardt K; Cremer-Schaeffer P; König J; Paeschke N
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):173-80. PubMed ID: 15726458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of the GCP guidelines in Europe.
    Geussenhainer S
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):223-8. PubMed ID: 8361259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of the Danish Medical Products Agency in clinical trials].
    Simonsen AC
    Ugeskr Laeger; 2003 Apr; 165(16):1653-6. PubMed ID: 12756821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GCP inspections in Germany and Europe following the implementation of the Directive 2001/20/EC.
    Göbel C; Baier D; Ruhfus B; Hundt F
    Ger Med Sci; 2009 Mar; 7():Doc01. PubMed ID: 19675741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
    Englev E; Petersen KP
    Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical drug trials. Regulation, coordination and significance of "Good Clinical Practice"].
    Hvidberg EF
    Ugeskr Laeger; 1994 Feb; 156(6):789-93. PubMed ID: 8016980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trials with minors in Germany--effects of the 12th amendment to the German Drug Code on the numbers of applications to Institutional Review Boards (IRB)].
    Kölch M; Märsch C; Fegert JM; Lippert HD
    Gesundheitswesen; 2009 Mar; 71(3):127-33. PubMed ID: 19221985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials].
    Dreier G; Marx C; Schmoor C; Maier-Lenz H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):445-52. PubMed ID: 15830256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic trial, clinical research and therapeutic freedom--legal boundaries].
    Deutsch E
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):698-700; discussion 701. PubMed ID: 9527472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of the 12th and 14th amendments to the AMG (Medical Preparations Act) on paediatric pharmaceutical research--a survey of the new regulations].
    Kölch M; Lippert HD; Fegert JM
    Z Kinder Jugendpsychiatr Psychother; 2006 Mar; 34(2):117-26. PubMed ID: 16610597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Consequences of the 12th AMG amendment on the conduct of non-commercial clinical trials].
    Rossion I
    Urologe A; 2005 Dec; 44(12):1444-8. PubMed ID: 16283155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences with GCP in the pharmaceutical industry [corrected].
    Rämsch KD
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):237-40. PubMed ID: 8240533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of women in clinical trials of drug therapies: a context for the controversies.
    Prout MN; Fish SS
    Medscape Womens Health; 2001 Oct; 6(5):1. PubMed ID: 11698923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.